Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease

Ophélie Fourdinier1, Griet Glorieux2, Benjamin Brigant3

  • 1Nephrology Dialysis and Transplantation Department, Amiens University Hospital, 80054 Amiens, France.

Insights

In chronic kidney disease (CKD), miR-126 levels correlate with endothelial dysfunction and uremic toxins. This finding offers new insights into CKD

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Chronic kidney disease (CKD) is a significant global health issue linked to high mortality.
  • Endothelial dysfunction and the accumulation of uremic toxins are key features of CKD.
  • Reduced miR-126 levels are observed in CKD patients, suggesting its role in disease pathology.

Purpose of the Study:

  • To investigate the relationship between miR-126 levels and markers of endothelial dysfunction in CKD patients.
  • To explore the association between miR-126 and key uremic toxins across all stages of CKD.
  • To elucidate the physiopathology of CKD by correlating miR-126 with specific biomarkers.

Main Methods:

  • Analysis of miR-126 levels in a large cohort of CKD patients.
  • Correlation studies using univariate and multivariate analyses.
  • Assessment of endothelial dysfunction markers and representative uremic toxins (e.g., indoxyl sulfate, p-cresyl glucuronide).

Main Results:

  • A significant correlation was found between estimated glomerular filtration rate (eGFR) and most evaluated endothelial dysfunction markers.
  • miR-126 was associated with all tested uremic toxins, unlike the control cel-miR-39.
  • Multivariate analysis confirmed the correlation between miR-126 and the endothelial dysfunction biomarker Syndecan-1, free indoxyl sulfate, and total p-cresyl glucuronide.

Conclusions:

  • miR-126 levels are significantly associated with endothelial dysfunction and uremic toxin accumulation in CKD.
  • These findings highlight the potential role of miR-126 in CKD pathophysiology.
  • Further research is warranted to evaluate the role of these correlated parameters in the reduced endothelial glycocalyx (eGC) observed in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
161
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
141
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
86
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
185
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
129
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
239